MINDACT: (EORTC) A Prospective, Randomised Study Comparing the 70-Gene Signature with the Common Clinical-Pathological Criteria in Selecting Patients for Adjuvant Chemotherapy in Node-Negative Breast Cancer (year 4 renewal)

  • Thompson, Alastair (Investigator)

    Project Details

    StatusFinished
    Effective start/end date1/10/11 → 30/09/17

    Funding

    • Cancer Research UK (C7636/A7714): £10,346.00
    • Cancer Research UK: £9,565.30
    • Cancer Research UK: £10,759.71
    • Cancer Research UK: £11,637.97
    • Cancer Research UK: £9,947.91
    • Cancer Research UK: £11,190.09